Literature DB >> 20631359

Clinical syndromes associated with ovarian neoplasms: a comprehensive review.

Alampady Krishna Prasad Shanbhogue1, Divya Krishna Prasad Shanbhogue, Srinivasa R Prasad, Venkateswar R Surabhi, Najla Fasih, Christine O Menias.   

Abstract

Functional ovarian neoplasms have unique clinical manifestations related to hormone overproduction and may give rise to a broad spectrum of clinical syndromes. Sex cord-stromal tumors, the most common functional ovarian neoplasms, are associated with either hyperestrogenism (as in granulosa cell tumor and thecoma) or hyperandrogenism (as in Sertoli-Leydig cell tumor and Leydig cell tumor). Other, less common ovarian neoplasms that may have endocrine or nonendocrine syndromic manifestations include germ cell tumors associated with the excessive production of human chorionic gonadotropin (eg, choriocarcinoma, dysgerminoma), monodermal teratomas (eg, carcinoid tumor, struma ovarii) associated with carcinoid syndrome and hyperthyroidism, and primary epithelial ovarian cancers associated with paraneoplastic syndromes. The application of diagnostic algorithms based on patient demographic information, clinical manifestations, laboratory findings, and cross-sectional imaging features may help identify ovarian neoplasms in complex clinical settings.

Entities:  

Mesh:

Year:  2010        PMID: 20631359     DOI: 10.1148/rg.304095745

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  18 in total

1.  Sclerosing stromal tumour of the ovary presenting as precocious puberty: a rare neoplasm.

Authors:  Jai Kumar Chaurasia; Nishat Afroz; Veena Maheshwari; Mohammed Naim
Journal:  BMJ Case Rep       Date:  2014-03-31

Review 2.  Imaging of pediatric ovarian neoplasms.

Authors:  Monica Epelman; Kudakwashe R Chikwava; Nancy Chauvin; Sabah Servaes
Journal:  Pediatr Radiol       Date:  2011-05-13

3.  A Case of Meigs' Syndrome: The (18)F-FDG PET/CT Findings.

Authors:  Eun Seong Lee; Tae-Sung Kim; Chong Woo Yoo; Sang-Soo Seo; Seok-Ki Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-07-15

4.  Ovarian tumors secreting insulin.

Authors:  Marialberta Battocchio; Maria Chiara Zatelli; Silvia Chiarelli; Mariangela Trento; Maria Rosaria Ambrosio; Claudio Pasquali; Eugenio De Carlo; Francesca Dassie; Roberto Mioni; Andrea Rebellato; Francesco Fallo; Ettore Degli Uberti; Chiara Martini; Roberto Vettor; Pietro Maffei
Journal:  Endocrine       Date:  2015-04-21       Impact factor: 3.633

5.  MRI diagnosis of ovarian fibrothecomas: tumour appearances and oestrogenic effect features.

Authors:  B Wu; W J Peng; Y J Gu; Y F Cheng; J Mao
Journal:  Br J Radiol       Date:  2014-03-27       Impact factor: 3.039

6.  Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.

Authors:  Ana Palha; Luísa Cortez; Ana Paula Tavares; Ana Agapito
Journal:  BMJ Case Rep       Date:  2016-11-01

Review 7.  Miscellaneous tumour-like lesions of the ovary: cross-sectional imaging review.

Authors:  N Lalwani; S Patel; K Y Ha; A K Shanbhogue; A M Nagar; K N Chintapalli; S R Prasad
Journal:  Br J Radiol       Date:  2012-01-17       Impact factor: 3.039

8.  Ovarian Clear Cell Carcinoma with Functioning Stroma and Associated Endometrial Intraepithelial Neoplasia.

Authors:  Fabian Desimpel; Jean-Christophe Noël; Laurine Verset; Nicolas Sirtaine; Frédéric Buxant
Journal:  Case Rep Obstet Gynecol       Date:  2022-07-06

9.  Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors.

Authors:  Keita Nagawa; Tomoki Kishigami; Fumitaka Yokoyama; Sho Murakami; Toshiharu Yasugi; Yasunobu Takaki; Kaiji Inoue; Saki Tsuchihashi; Satoshi Seki; Yoshitaka Okada; Yasutaka Baba; Kosei Hasegawa; Masanori Yasuda; Eito Kozawa
Journal:  J Ovarian Res       Date:  2022-05-25       Impact factor: 5.506

10.  "Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging.

Authors:  Rosa Maria Paragliola; Francesco Torino; Paola Senes; Laura Castellino; Vanda Salutari; Alfredo Pontecorvi; Giovanni Scambia; Salvatore M Corsello
Journal:  Endocrine       Date:  2013-10-04       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.